Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» regulatory
regulatory
Canada’s drug price reforms delayed to 2021
RAPS.org
Tue, 06/2/20 - 11:15 pm
Canada
regulatory
drug pricing
EMA weighs COVID-19 data transparency, not ready to resume full clinical data publication
RAPS.org
Tue, 06/2/20 - 11:00 am
EMA
Europe
regulatory
clinical trial transparency
COVID-19
pandemic
FDA explains impact of COVID-19 on applications, formal meetings
RAPS.org
Wed, 05/27/20 - 11:57 pm
FDA
regulatory
pandemic
COVID-19
New Developments in FDA Regulation of AI
Medical Devices and Diagnostics Industry
Fri, 04/10/20 - 10:39 am
FDA
artificial intelligence
regulatory
Ex-FDA chief says regulator needs to up pace on COVID-19 drugs
Fierce Biotech
Mon, 04/6/20 - 10:41 am
Scott Gottlieb
FDA
regulatory
COVID-19
Trump administration uses wartime powers to be first in line on medical supplies
MedCity News
Fri, 04/3/20 - 06:36 pm
Donald Trump
regulatory
medical supplies
COVID-19
Coronavirus Relief Bill Includes OTC Drug User Fee Program
RAPS.org
Fri, 03/27/20 - 12:09 am
COVID-19
OTC
user fees
drug shortages
legislation
regulatory
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
FDA
regulatory
Bristol-Myers Squibb
ozanimod
Esteve
E-58425
Fabre-Kramer
AstraZeneca
Imfinzi
Astellas
Vesicare
AbbVie
Neurocrine
Orlissa
Sanofi
MenQuadfi
opicapone
Acceleron
Reblozyl
FDA to Implement All COVID-19-Related Guidance Immediately, Without Public Comment
RAPS.org
Sat, 03/21/20 - 12:03 am
FDA
COVID-19
regulatory
Will COVID-19 Derail New Drugs?
Motley Fool
Wed, 03/18/20 - 10:32 am
COVID-19
SEC
regulatory
clinical trials
Bayer and MassBio teach startups regulatory ins and outs at new center
Fierce Pharma
Wed, 03/11/20 - 10:57 am
regulatory
Bayer
MassBio
startups
Georgia bill seeks lower drug prices by focusing on middlemen
Atlanta Journal Constitution, GA
Fri, 02/14/20 - 05:02 pm
drug pricing
PBMs
Georgia
legislation
regulatory
Government spending bill tweak means 3 more NDAs will become BLAs, FDA says
Endpoints
Thu, 01/16/20 - 10:24 am
legislation
regulatory
biologics
NDAs
BLAs
FDA
Washington took a decade to approve an obscure drug-pricing bill. That’s a bad omen for more ambitious reforms
Stat
Tue, 01/7/20 - 10:35 am
drug pricing
regulatory
legislation
Donald Trump
FiercePharmaPolitics—Pharma price hikes rang in 2020, but how will Washington respond?
Fierce Pharma
Mon, 01/6/20 - 10:45 am
drug pricing
legislation
regulatory
2020 Presidential election
Annual Ritual Of Drug Price Increases To Get More Political Scrutiny In 2020
Forbes
Sat, 01/4/20 - 07:34 pm
drug pricing
2020 Presidential election
regulatory
Medtech Trends to Watch in 2020
Medical Devices and Diagnostics Industry
Fri, 01/3/20 - 09:58 am
devices
digital health
5G
wearables
data
robotics
personalized medicine
IVDs
homecare
sterlization
startups
regulatory
PhRMA Challenges Oregon Drug Pricing Transparency Laws
FDA Law Blog
Thu, 01/2/20 - 10:42 am
PhRMA
Oregon
regulatory
drug pricing
transparency
Pharma fury as Trump’s team reneges on biologic patent rules in trade talks
Pharmaforum
Thu, 12/12/19 - 11:10 am
trade
biologics
drug pricing
regulatory
Canada
Mexico
China
How The House Prescription Drug Plan Would Try To Lower Drug Prices
NPR
Thu, 12/12/19 - 10:56 am
drug pricing
legislation
regulatory
Lower Drug Costs Now Act of 2019
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »